ArticleInfectious diseases and therapy2025

Estimating the Public Health and Economic Impact of Immunisation with Nirsevimab or Maternal Immunisation for the Prevention of RSV-Related Outcomes Over Infants' First RSV Season in the UK.

Mersha Chetty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.